Spot and Tubular data show prescription immunology brands continued to dominate TV, while seasonal OTC brands found scale on ...
So first, let's consider Viking's story so far. The company is working on a dual GLP-1/GIP receptor agonist in injectable and oral formats. Injectable VK2735 is involved in a phase 3 trial right now, ...
Nine states have been pursuing the idea of prescription drug affordability boards. Maryland's board just set limits on the ...
One in eight American adults is taking GLP-1s. What does that mean for how we relate to our food, bodies and one another?
A new Apple TV 4K is rumored to launch this fall with AI support, and the latest Netflix feature offers a helpful example of how AI might benefit the Apple TV. Apple Intelligence is rumored to hit ...
Keeping up with Kris Jenner’s weight loss. The reality star admitted to “She MD” podcast listeners on Tuesday that she tried Ozempic before it was trendy. “We tried it once when no one knew what it ...
Amazon Pharmacy (NASDAQ: AMZN), a full-service digital pharmacy that delivers medications directly to customers' homes, is expanding access to Novo Nordisk's Ozempic® pill, the only FDA-approved oral ...
Share on Pinterest Ozempic is now available as a reformulated oral tablet for people with type 2 diabetes. Image courtesy of Novo Nordisk The GLP-1 medication Ozempic is now available in pill form for ...
Ozempic is now available as a reformulated oral tablet for people with type 2 diabetes. Image courtesy of Novo Nordisk A pill form of the widely prescribed GLP-1 medication Ozempic is now available in ...
Kelly Anne is a deputy editor at Forbes Advisor overseeing the development of various initiatives, including newsletters, social media, and new content verticals. Previously, she worked as a senior ...
Credit: Novo Nordisk. The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results